📰 Accustem Sciences News
Accustem Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Accustem Sciences. Real-time updates on events, politics, business and more.
May 20, 2024
AccuStem Sciences, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 0.526602 million compared to USD 0.833341...
May 2, 2023
LONDON and PHOENIX, May 02, 2023 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced today
October 10, 2022
LONDON and PHOENIX, Oct. 10, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB:ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced today
September 13, 2022
LONDON and PHOENIX, Ariz., Sept. 13, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced
April 28, 2022
Investegate announcements from AccuStem Sciences, Inc, AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
April 28, 2022
LONDON and PHOENIX, April 28, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a life sciences company dedicated to improving outcomes for...
April 14, 2022
Investegate announcements from AccuStem Sciences, Inc, AccuStem Sciences, Inc. Announces DTC Eligibility
April 5, 2022
LONDON and PHOENIX, April 05, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTC Pink: ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, announced that it has
April 5, 2022
Investegate announcements from AccuStem Sciences, Inc, AccuStem Announces Private Placement of Common Stock
March 23, 2022
Investegate announcements from AccuStem Sciences, Inc, AccuStem Sciences, Inc. Announces DTC Eligibility